Tempus AI, Inc. is a technology company advancing precision medicine through the practical application of artificial intelligence in healthcare. It offers AI-enabled precision medicine solutions to physicians to deliver personalized patient care and, in parallel, facilitates discovery, development and delivery of optimal therapeutics. It provides three product lines: Genomics, Data and artificial intelligence applications (AI). The Genomics product line leverages its laboratories to provide next generation sequencing (NGS) diagnostics, polymerase chain reaction, profiling, molecular genotyping and other anatomic and molecular pathology testing. The data generated in its lab or ingested into its platform is structured and de-identified, prior to commercialization. Its AI Applications is focused on developing and providing diagnostics that are algorithmic in nature, implementing new software as a medical device, and building and deploying clinical decision support tools.
Company Information
About this company
Key people
Eric P. Lefkofsky
Chairman of the Board, Chief Executive Officer, Founder
David R. Epstein
Independent Director
Wayne A.I. Frederick
Independent Director
James Rogers
Chief Financial Officer
Ryan Fukushima
Chief Executive Officer - Data
Tom Schoenherr
Chief Executive Officer - Diagnostics
Andrew Polovin
Executive Vice President, Chief Legal Officer and Secretary
Erik J. Phelps
Chief Administrative Officer
Peter J. Barris
Independent Director
Eric D. Belcher
Independent Director
Jennifer A. Doudna
Independent Director
Click to see more
Key facts
- Shares in issue174.70m
- EPICTEM
- ISINUS88023B1035
- LocationUnited States
- SectorHealthcare
- IndustryBiotechnology & Drugs
- Market cap$8.95bn
- Employees3,800
- ExchangeNASDAQ
- IndexTR Equity United States Index
- Website
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.